Barclays Upgrades Relx (NYSE:RELX) to Overweight

Relx (NYSE:RELXGet Free Report) was upgraded by equities research analysts at Barclays from an “equal weight” rating to an “overweight” rating in a report issued on Friday, Marketbeat Ratings reports.

Several other equities research analysts have also issued reports on the company. Redburn Atlantic started coverage on Relx in a research report on Wednesday, January 8th. They set a “buy” rating for the company. StockNews.com lowered shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th.

View Our Latest Stock Analysis on RELX

Relx Stock Performance

RELX stock opened at $48.99 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46. The firm has a market cap of $91.04 billion, a PE ratio of 26.34, a P/E/G ratio of 2.73 and a beta of 0.90. The business has a 50 day moving average of $48.86 and a 200-day moving average of $47.60. Relx has a 12-month low of $40.25 and a 12-month high of $51.99.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Ameriprise Financial Inc. increased its holdings in Relx by 368.7% in the 4th quarter. Ameriprise Financial Inc. now owns 2,807,038 shares of the technology company’s stock worth $127,437,000 after acquiring an additional 2,208,119 shares during the last quarter. Raymond James Financial Inc. bought a new position in Relx during the fourth quarter worth about $44,516,000. Northern Trust Corp increased its stake in shares of Relx by 51.6% in the fourth quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company’s stock worth $99,542,000 after purchasing an additional 745,532 shares in the last quarter. Bank of Montreal Can raised its position in shares of Relx by 290.3% in the fourth quarter. Bank of Montreal Can now owns 886,758 shares of the technology company’s stock valued at $40,277,000 after purchasing an additional 659,547 shares during the period. Finally, Arrowstreet Capital Limited Partnership lifted its stake in shares of Relx by 50.3% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,968,739 shares of the technology company’s stock valued at $89,420,000 after buying an additional 658,655 shares in the last quarter. Hedge funds and other institutional investors own 15.02% of the company’s stock.

About Relx

(Get Free Report)

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Read More

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.